Emmed Clinical Research

Pretoria, Gauteng 0002

0 studies enrolling now · 2 studies all time

What they study most

Cardiovascular Risk, Chronic Kidney Disease, Community-acquired Pneumonia, Inflammation

Studies at this site

• Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP) — Recruiting now
• ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation — Completed